Update on hepatitis C virus resistance to direct-acting antiviral agents
Author:
Publisher
Elsevier BV
Subject
Virology,Pharmacology
Reference89 articles.
1. The AASLD/IDSA Clinical Guidance for Hepatitis C. March 21, 2014. Available from: .
2. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;N. Engl. J. Med.,2014
3. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N. Engl. J. Med.,2014
4. Selected replicon variants with low-level in vitro resistance to the hepatitis C virus NS5B polymerase inhibitor PSI-6130 lack cross-resistance with R1479;Ali;Antimicrob. Agents Chemother.,2008
5. Sofosbuvir-based interferon-free therapy for patients with HCV infection;Asselah;J. Hepatol,2013
Cited by 172 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review;Microorganisms;2024-05-21
2. Effectiveness and safety of SOF/VEL containing rescue therapy in treating chronic HCV-GT4 patients previously failed NS5A inhibitors-based DAAs;Egyptian Liver Journal;2024-03-11
3. In-silico investigation on the discovery of synthesized nucleoside-based antivirals against monkeypox and SARS-CoV-2 Virus;2024-02-14
4. Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development;Journal of Biological Chemistry;2023-06
5. Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients;Heliyon;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3